PRPH News and Press, ProPhase Labs Inc. From 10/12/23

ROCHESTER, N.Y., Oct. 12, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, announced today that it has i...

2023-08-12 11:04:08 ET ProPhase Labs, Inc. (PRPH) Q2 2023 Earnings Conference Call August 10, 2023 11:00 AM ET Company Participants Ted Karkus - Chairman and CEO Conference Call Participants Adam Waldo - Lismore Partners Dennis Waldman - Barrett Productio...

Garden City, NY, Aug. 10, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) Conference Call and Webcast Details Management will host a conference call at 11:00 AM ET, Thursday, August 10, 2023, to provide an update on corporate developments and review financial results. ...

2023-08-10 09:19:43 ET ProPhase Labs press release ( NASDAQ: PRPH ): Q2 GAAP EPS of -$0.20 misses by $0.06 . Revenue of $13.22M (-54.6% Y/Y) misses by $0.92M . The decrease in net revenue was the result of a $18.3 million decrease in net revenue from diagnostic...

Company believes that the combined value of its five operating units exceeds its current market capitalization and that each unit has significant growth potential. Company highlights successful transition from reliance on COVID-19 testing to diversified growth opportunities in genomics, b...

2023-08-09 13:02:08 ET ProPhase Labs ( NASDAQ: PRPH ) is scheduled to announce Q2 earnings results on Thursday, August 10th, before market open. The consensus EPS Estimate is -$0.14 and the consensus Revenue Estimate is $14.14M (-51.4% Y/Y). Over the last 3 months, EPS...

Garden City, NY, Aug. 03, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next generation biotech, genomics, therapeutics and diagnostics company, today provided an update regarding its progress and development strategy for Linebacker-1 (LB-1), a small ...

GARDEN CITY, NY, Aug. 02, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, will hold a conference call on Thursday, August 10, 2023, at 11:00 a.m. Eastern time to discuss its results for the second quart...

2023-06-29 09:40:49 ET ProPhase Labs ( NASDAQ: PRPH ) said Thursday it recently made an unsolicited non-binding offer to acquire certain assets from Navidea Biopharmaceuticals ( NAVB ), which was rejected . Navidea ( NAVB ) did not make a counteroffer nor did ...

Garden City, NY, June 29, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next generation biotech, genomics and diagnostics company, today announced that it recently made an unsolicited offer to acquire certain assets from NYSE American listed Navidea B...